575 results on '"Campieri M"'
Search Results
2. P571 Can Crohnʼs colits be cured by surgery?
3. P581 Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patients: a double-blind, randomized, placebo controlled trial
4. New insights into the brain involvement in patients with Crohn’s disease: a voxel-based morphometry study
5. Medical treatment and management of severe ulcerative colitis
6. CT-guided percutaneous pelvic abscess drainage in Crohn’s disease
7. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
8. Local Injection of Infliximab for the Treatment of Perianal Crohn’s Disease
9. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
10. The effect of transient intestinal ischemia on inflammatory parameters
11. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
12. Risk of permanent stoma in extensive Crohnʼs colitis: the impact of biological drugs
13. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study
14. Use of anti-tumour necrosis factor agents in inflammatory bowel disease: European guidelines for 2001–2003
15. New steroids and new salicylates in inflammatory bowel disease: A critical appraisal. (Paper)
16. Distinct proteomic profiles characterise non-erosive from erosive reflux disease
17. Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease
18. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
19. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX® with Asacol®
20. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
21. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis
22. Oral budesonide in the treatment of chronic refractory pouchitis
23. Review article: aminosalicylates for distal colitis
24. Antibiotic treatment of Crohnʼs disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
25. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients
26. Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches
27. Probiotics and barrier function in colitis
28. Microbiology
29. Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland
30. Modulation of human dendritic cell phenotype and function by probiotic bacteria
31. problematic proctitis and distal colitis
32. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation
33. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
34. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study
35. Review article: medical treatment of severe ulcerative colitis
36. Treatment of distal colitis
37. Monitoring activity in ulcerative colitis
38. The management of refractory Crohn's disease
39. Treatment of mild to moderate ulcerative colitis and pouchitis
40. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
41. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis
42. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis
43. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study
44. MCP-3 in inflammatory bowel disease
45. Ultrasonographic findings in Crohnʼs disease
46. Rifaximin systemic absorption in patients with ulcerative colitis
47. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis
48. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
49. RIFAXIMIN IN PATIENTS WITH MODERATE OR SEVERE ULCERATIVE COLITIS REFRACTORY TO STEROID-TREATMENT: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
50. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.